High Tide Inc.

NASDAQ:HITI

Medical - Pharmaceuticals

Healthcare
$2.37 -2.11%

-$0.05 today

Market cap
$211.27M
Beta
0.57
P/E (TTM)
-6.6
EPS (TTM)
-$0.50
52W Low $2.12High $4.06

Volume 0.32M

Average 0.61M

HITI Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

High Tide Inc.NASDAQ: HITI

Capital Expenditures · Q2 FY2026 · quarter ended Apr 2026

Capital expenditures declines year over year

Q2 FY2026 capital expenditures of CA$2.09M (cash outflow) fell 18.3% year over year, behind the -5.9% change in trailing-twelve-month capital expenditures. Sequentially, it fell 22.5% from the prior quarter. Over 3 fiscal years it compounded at +5.5% a year.

Context

  • Capital expenditures amounted to 1.8% of revenue in FY2025, unchanged from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -18.3% toward the trailing-twelve-month pace of -5.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterApr 2026
-CA$2.09M-22.5% QoQ
Last fiscal yearOct 2025
-CA$10.65M+9.2% YoY
LTMApr 2026
-CA$10.14M-5.9% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-18.3%——
1 year+9.2%——
3-year CAGR+5.5%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

CAD · from the cash flow

Latest · FY2025
(10.65M) CAD
Year-over-year change
-9.2%

Capital Expenditures vs competitors

How HITI compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -5.9% is the 3rd highest of 6, against a peer median of -37.4%.
  • Capital expenditures amounts to 1.5% of revenue for HITI, versus a peer median of 2.6%.
HITI Competitors
Capital Expenditures for HITI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CRON.TOCronos Group Inc.LTM Mar 2026$12.43M USD-53.1%+73.2%7.8%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$11.19M CAD+1.5%—4.1%
HITIHigh Tide Inc.LTM Apr 2026CA$10.14M CAD-5.9%+5.5%1.5%
TSND.TOTerrAscend Corp.LTM Mar 2026$6.87M USD-37.4%-45.7%2.6%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$6.44M CAD-42.9%-17.4%2.1%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$3.26M CAD+29.2%-35.1%2.1%
Peer median (excluding HITI) —-37.4%-26.2%2.6%

Competitors are the stored peer set for HITI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Net Income(35.04M)(70.85M)(40.95M)(3.81M)(51.4M)
Depreciation & Amortization23.57M30.17M32.76M25.39M24.31M
Deferred Income Tax(730K)(2.92M)(7.64M)(593K)(25K)
Stock-Based Compensation4.88M8.08M5.03M2.98M3.92M
Change in Working Capital(9.9M)(4.61M)(4.86M)3.04M(294K)
Accounts Receivables(3.29M)(3.74M)627K4.27M(1.34M)
Inventory(5.5M)(2.87M)(2.87M)(3.32M)(5.81M)
Accounts Payables00000
Other Working Capital(1.11M)1.99M(2.62M)2.1M6.86M
Other Non-Cash Items14.4M44.62M36.33M8.54M47.36M
Operating Cash Flow(2.83M)4.5M20.66M35.55M23.87M
Capital Expenditures(10.71M)(9.06M)(6.08M)(9.75M)(10.65M)
Acquisitions (Net)(19.73M)463K270K(600K)(12.29M)
Purchases of Investments(507K)00(660K)0
Sales of Investments0095K0648K
Other Investing Activities2.31M(1.3M)(295K)(703K)(209K)
Investing Cash Flow(28.49M)(8.59M)(5.72M)(11.01M)(22.29M)
Debt Repayment(10.08M)(3.8M)(11.38M)(10.92M)1.27M
Common Stock Issued38.57M21.9M2.6M3.49M628K
Common Stock Repurchased00000
Dividends Paid0(1.96M)(456.65K)(199.72K)(1.4M)
Other Financing Activities9.32M(979.72K)(32.35K)(97.28K)(292.19K)
Financing Cash Flow37.81M15.17M(9.26M)(7.72M)202K
Effect of Forex Changes00(646K)333K(1.16M)
Net Change in Cash6.49M11.07M5.04M17.15M616K
Free Cash Flow(13.54M)(4.56M)14.58M25.8M13.22M

High Tide Inc.

NASDAQ:HITI

Intrinsic Alpha fair value

Locked

Current Price

$2.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.